On September 1, 2025, Cyclacel Pharmaceuticals announced the issuance of amended series of common stock purchase warrants, allowing holders to buy 218,000 shares each at prices of $7.65, $9.00, and $10.20 without the previous ownership limitations. This significant change was approved by the Board and is aimed at facilitating stockholder engagement.